News

Filter

Current filters:

None

120 to 129 of 96284 results

Orphan status for Navidea’s Lymphoseek in head and neck cancers

Orphan status for Navidea’s Lymphoseek in head and neck cancers

19-09-2014

US biotech company Navidea Biopharmaceuticals that its Lymphoseek (technetium Tc 99m tilmanocept) Injection…

BiotechnologyLymphoseekNavidea BiopharmaceuticalsOncologyRegulationUSA

First domestic-made erectile dysfunction drug debuts in China

19-09-2014

A Chinese pharmaceutical company on Thursday launched the country's first domestic-made erectile dysfunction…

Bai Yun Shan PharmaceuticalChinaJingeMarkets & MarketingMen's HealthPharmaceutical

Swedish Orphan Biovitrum adds new molecule to its hemophilia collaboration with Biogen Idec

Swedish Orphan Biovitrum adds new molecule to its hemophilia collaboration with Biogen Idec

19-09-2014

Nordic biotech firm Swedish Orphan Biovitrum has added the preclinical fusion molecule rFVIIIFc-XTEN-vWF…

Biogen IdecBiotechnologyHematologyLicensingSobiSweden

FDA approves Lilly’s Trulicity to treat type 2 diabetes

FDA approves Lilly’s Trulicity to treat type 2 diabetes

19-09-2014

The US Food and Drug Administration yesterday approved pharma major Eli Lilly’s Trulicity (dulaglutide),…

BydureonDiabetesdulaglutideEli LillyPharmaceuticalRegulationTanzeumTrulicityUSAVictoza

Merck KGaA promotes pharma CEO Stefan Oschmann to deputy CEO

Merck KGaA promotes pharma CEO Stefan Oschmann to deputy CEO

18-09-2014

The board of partners of Germany’s Merck KGaA has promoted Stefan Oschmann to the position of deputy…

BoardroomGermanyMerck KGaAPharmaceuticalStefan Oschmann

NICE and ABPI call for reform of drug appraisals after consultation

NICE and ABPI call for reform of drug appraisals after consultation

18-09-2014

The UK’s Association of the British Pharmaceutical Industry (ABPI) has called for a “more ambitious…

Care ExcellenceHealthcareNHSPharmaceuticalUK

Biogen and AbbVie report reduced disease activity with MS drug Zinbryta

Biogen and AbbVie report reduced disease activity with MS drug Zinbryta

18-09-2014

US biotech company Biogen Idec and US pharma giant AbbVie have announced the full results from the Phase…

AbbVieAvonexBiogen IdecImmune systemMultiple sclerosisNeurologicalPharmaceuticalResearchUSAZinbryta

Bayer plans to focus entirely on Life Science businesses

Bayer plans to focus entirely on Life Science businesses

18-09-2014

The board of management of Germany’s Bayer AG plans to focus the Bayer Group entirely on the Life Science…

BayerFinancialGermanyManagementPharmaceutical

120 to 129 of 96284 results

Back to top